Xarelto problems lead to title 2016 highest priority drug safety problem

According to the Institute for Safe Medication Practices’ QuarterWatch, an organization that monitors drug safety trends new oral anticoagulants (NOAC drugs), Pradaxa, Eliquis and Xarelto problems have earned them the title of 2016’s highest priority drug safety problem.These NOAC drugs cause bleeding injuries in 8% […]

Jul 30, 2017
Xarelto

Pradaxa and Xarelto Problems 2016 Highest Priority Drug Safety Problem